Giant Eyelid Eccrine Hidrocystoma: A Case Report

Anjali Agrawal *

Department of Ophthalmology, Chhattisgarh Institute of Medical Sciences, Bilaspur, C.G., India.

Suchita Singh

Department of Ophthalmology, Chhattisgarh Institute of Medical Sciences, Bilaspur, C.G., India.

*Author to whom correspondence should be addressed.


Aims: To report a case of a rare giant eyelid eccrine hidrocystoma confirmed on histopathological examination and successful surgical excision with no recurrence.

Presentation of Case: A young male presented with a mass over his eyelid which was gradually increasing in size, leading to drooping of the upper eyelid with no other associated symptoms. The mass 20x15x10 mm was present over the upper lid, non-mobile, non-tender, and firm. On the CT scan, a well-defined round to oval hypodense cystic mass was seen to be originating from the left upper eyelid. The cyst was excised and sent for histopathological analysis. The histological appearance of cystic spaces lined by cuboidal epithelium and containing mucinous fluid was suggestive of eccrine hidrocystoma. There was no recurrence till 2 months of follow-up.

Conclusion: Eccrine hidrocystomas are 1-6 mm in size, generally 4 mm, and cysts larger than 10 mm are rare. Larger cysts have been described as “giant eccrine hidrocystoma.” Giant eyelid eccrine hidrocystoma is an unusual condition of the eyelid that must be considered in the differential diagnosis of eyelid tumours. They can be managed by complete surgical excision although recurrences are found to be common.

Keywords: Eccrine, hidrocystoma, giant, eyelid tumour

How to Cite

Agrawal, A., & Singh , S. (2023). Giant Eyelid Eccrine Hidrocystoma: A Case Report. Ophthalmology Research: An International Journal, 18(3), 11–16.


Download data is not yet available.


Hodge BD, Sanvictores T, Brodell RT. Anatomy, Skin Sweat Glands. 2022 Oct 10. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 29489179.

Alfadley A, Al Aboud K, Tulba A, Mourad MM. Multiple eccrine hidrocystomas of the face. Int J Dermatol. 2001;40(2):125-9. DOI:10.1046/j.1365-4362.2001.01126.x. PMID: 11328394.

Smith JD, Chernosky ME. Hidrocystomas. Arch Dermatol. 1973;108(5):676-9. PMID: 4750204.

Robinson AR. Hidrocystoma. J Cut Gen Urin Dis. 1893;11:292-303.

Singh AD, McCloskey L, Parsons MA, Slater DN. Eccrine hidrocystoma of the eyelid. Eye (Lond). 2005;19(1):77-9.

DOI:10.1038/sj.eye.6701404. PMID: 15205675.

Eslami F, Mahdavi Rafi A, Ghasemi Basir HR. A case report of eccrine hidrocystoma. Avicenna J Clin Med. 2020; 26(4):247-251

Sheth HG, Raina J. Giant eccrine hidrocystoma presenting with unilateral ptosis and epiphora. Int. Ophthalmol. 2008; 28(6):429-31. DOI:10.1007/s10792-007-9153-7. Epub 2007 Oct 6. PMID: 17922081.

Ssi-Yan-Kai IC, Pearson AR. Recurrent giant orbital apocrine hidrocystoma. Eye (Lond). 2012;26(6):895-6.

DOI: 10.1038/eye.2012.57. Epub 2012 Apr 13. PMID: 22498797; PMCID: PMC3376301.

Kim YD, Lee EJ, Song MH, Suhr KB, Lee JH, Park JK. Multiple eccrine hidrocystomas associated with Graves' disease. Int J Dermatol. 2002;41(5):295-7. DOI:10.1046/j.1365-4362.2002.01356_5.x. PMID: 12100710.

Sarabi K, Khachemoune A. Hidrocystomas- A brief review. Med Gen Med. 2006;8(3):57.

PMID: 17406184; PMCID: PMC1781304.

Pe'er J. Pathology of eyelid tumors. Indian J Ophthalmol. 2016;64(3):177-90.

DOI:10.4103/0301-4738.181752. PMID: 27146927; PMCID: PMC4869455.

Amirhoushang E, Mostafa MS, Maryam A, Pardis N, Pedram N. Topical 0.03% Atropine vs. 15% aluminum chloride in treating multiple eccrine hidrocystomas: a randomized single blind controlled study. Indian J Dermatol. 2010;55(1):47-9. DOI:10.4103/0019-5154.60352. PMID: 20418978; PMCID: PMC2856374.